Jason Ehrlich, MD, PhD

Jason Ehrlich remained at Genentech as a full-time member of the Clinical Ophthalmology group. I am the clinical lead for Lucentis development programs in Diabetic Macular Edema, and am the Medical Monitor for two international Phase III studies. I am also the Clinical representative for the Lucentis Safety Team and have continued my work in ophthalmic diagnostics and pharmacogenomics. I work extensively with colleagues in Biostatistics and provide clinical guidance on publications, presentations, and exploratory analyses related to Lucentis clinical trials. I've also had the opportunity to assist in the development of clinical strategies for new Lucentis programs, and provide clinical expertise to a wide range of business partners at Genentech, including colleagues in our Commercial/Marketing and Business Development groups.